Primary CNS lymphoma. Infratentorial localization and prolonged survival.

被引:0
|
作者
Grinberg, A
Muchnik, S
Cura, L
Parera, IC
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A case of a 35-year-old woman presenting infratentorial CNS lymphoma is reported. In 1990 she complained of diplopia, blurred vision and left horizontal nistagmus. An MRI disclosed a lesion in the medulla, pens, and cerebellar vermis and peduncles. Although no treatment was administered, a later RM[ showed less extension of the tumor. One year after clinical diagnosis, she received corticosteroids; during the second year a stereotaxic biopsy of the cerebellar lesion was done showing a diffuse B cell non-Hodgkin's lymphoma. A whole brain irradiation was given (50 Gy). She did well for five years, and remains alive (79 months).
引用
收藏
页码:712 / 715
页数:4
相关论文
共 50 条
  • [21] Value of autologous stem cell transplantation in first line therapy of primary CNS lymphoma.
    Colombat, P
    Le Mevel, A
    Delwail, V
    Foussard, C
    Brion, A
    Berthou, C
    Bay, JO
    Quesnel, B
    Quittet, P
    Himberlin, C
    Delepine, R
    Desablens, B
    Lamy, T
    BLOOD, 2002, 100 (11) : 644A - 644A
  • [22] First line ABMT for primary CNS lymphoma. Unicentric experience on 8 patients.
    Desablens, B
    Garidi, R
    Tabuteau, S
    Fernandes, J
    Royer, B
    Villard, F
    Colombat, P
    Krzisch, C
    BLOOD, 2002, 100 (11) : 648A - 648A
  • [23] Penetration of Yttrium-90-labeled ibritumomab tiuxetan (Zevalin™) into primary CNS lymphoma.
    Kiewe, Philipp
    Korfel, Agnieszka
    Maza, Sofiane
    Jahnke, Kristoph
    Munz, Dieter L.
    Thiel, Eckhard
    BLOOD, 2006, 108 (11) : 770A - 770A
  • [24] Prognostic Factors and Survival in Primary CNS Lymphoma Patients at Yale
    Prado, Isabel
    Barbiero, Frank
    Baehring, Joachim
    Becker, Kevin
    Corbin, Zachary
    NEUROLOGY, 2019, 92 (15)
  • [25] PRIMARY CNS LYMPHOMA TREATED WITH OSMOTIC BLOOD-BRAIN-BARRIER DISRUPTION - PROLONGED SURVIVAL AND PRESERVATION OF COGNITIVE FUNCTION
    NEUWELT, EA
    GOLDMAN, DL
    DAHLBORG, SA
    CROSSEN, J
    RAMSEY, F
    ROMANGOLDSTEIN, S
    BRAZIEL, R
    DANA, B
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (09) : 1580 - 1590
  • [26] Increasing use of immunotherapy and prolonged survival among younger patients with primary CNS lymphoma: a population-based study
    Neuhauser, Magdalena
    Roetzer, Thomas
    Oberndorfer, Stefan
    Kitzwoegerer, Melitta
    Payer, Franz
    Unterluggauer, Julia J.
    Haybaeck, Johannes
    Stockhammer, Guenther
    Iglseder, Sarah
    Moser, Patrizia
    Thome, Claudius
    Stultschnig, Martin
    Wuertz, Franz
    Brandner-Kokalj, Tanisa
    Weis, Serge
    Bandke, Dave
    Pichler, Josef
    Hutterer, Markus
    Krenosz, Karl J.
    Boehm, Alexandra
    Mayrbaeurl, Beate
    Hager-Seifert, Andrea
    Kaufmann, Hannes
    Dumser, Martina
    Reiner-Concin, Angelika
    Hoenigschnabl, Selma
    Kleindienst, Waltraud
    Hoffermann, Markus
    Dieckmann, Karin
    Kiesel, Barbara
    Widhalm, Georg
    Marosi, Christine
    Jaeger, Ulrich
    Hainfellner, Andreas
    Hackl, Monika
    Hainfellner, Johannes A.
    Preusser, Matthias
    Woehrer, Adelheid
    ACTA ONCOLOGICA, 2019, 58 (07) : 967 - 976
  • [27] Primary CNS lymphoma
    Maher, EA
    Fine, HA
    SEMINARS IN ONCOLOGY, 1999, 26 (03) : 346 - 356
  • [28] Primary CNS lymphoma
    Petzold, A
    Zellner, A
    Lommatzsch, R
    Lommatzsch, P
    OPHTHALMOLOGE, 2001, 98 (04): : 414 - 415
  • [29] PRIMARY CNS LYMPHOMA
    CHAMBERLAIN, MC
    NEUROLOGY, 1995, 45 (05) : 1031 - 1032
  • [30] Primary CNS lymphoma
    Batchelor, T
    Loeffler, JS
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (08) : 1281 - 1288